Prenatal diagnosis of pulmonary arteriovenous malformations (PAVM), caused by abnormal communications between pulmonary arteries and pulmonary veins, is rarely described. We report a case of a PAVM between the right pulmonary artery and the left atrium, referred to our prenatal unit at 22 + 1 weeks of gestation, with severe cardiomegaly, dilation of the right pulmonary artery and a right pulmonary vein and retrograde flow in the ductus arteriosus. The fistula was located in the right lung and showed a broad, disturbed flow at color Doppler with high velocity and low pulsatility. The fetus was monitored weekly and cardiac function remained sufficient until 36 + 1 weeks of gestation, when increasing cardiomegaly prompted delivery by cesarean section. The newborn was transferred to the neonatal intensive care unit, intubated and the fistula was surgically removed. The boy could be discharged at the 43rd day of life and showed an uneventful course until the last follow-up at the age of 4 years, with no residual mental or physical handicaps and a normal cardiac function. Despite adverse outcomes described in previously reported cases of large PAVM complicated by severe cardiomegaly at midtrimester scan, our case had a good outcome.

Keywords:
Fetus, Arteriovenous malformation, Pulmonary arteries and veins, Cardiomegaly, Hydrops, Color Doppler flow
1.
Gossage J, Kanj G: Pulmonary arteriovenous malformations. Am J Resp Crit Care Med 1998;158:643-661.
2.
Heling KS, Tennstedt C, Goldner B, Bollmann R: Prenatal diagnosis of intrapulmonary arteriovenous malformation: sonographic and pathomorphological findings. Ultrasound Obstet Gynecol 2002;19:514-517.
3.
Jakobi P, Winer Z, Best L, Itskovitz-Eldor J: Hereditary hemorrhagic telangiectasia with pulmonary arteriovenous malformations. Obstet Gynecol 2001;97:913-914.
4.
Akler G, Tamir A, Malinger G, Yagel S: Prenatal diagnosis of a pulmonary arteriovenous malformation. Ultrasound Obstet Gynecol 2012;39:235-237.
5.
Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R: International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73-87.
6.
Liechty KW, Flake AW: Pulmonary vascular malformations. Semin Pediatr Surg 2008;17:9-16.
7.
Kalugdan RG, Shoji S, Koyanagi T, Shinzato Y, Nakano H: Antenatal diagnosis of pulmonary arteriovenous fistula using real-time ultrasound and color Doppler flow imaging. J Clin Ultrasound 1989;17:607-614.
8.
Russell MW, Gomez C, Nugent C, Christiansen J: Large fetal pulmonary arteriovenous fistula: impact on pulmonary development. Pediatr Cardiol 2002;23:454-457.
9.
Sinkovskaya E, Berkley E, Bogdan D, Sclater A, Abuhamad A: The role of echocardiography in prenatal diagnosis of pulmonary arteriovenous malformation: Prenatal Diagn 2009;29:634-636.
10.
Kenny DP, Tsai-Goodman B, Martin RP, Tulloh RM: Antenatal diagnosis and postnatal treatment of intrapulmonary arteriovenous malformation. Arch Dis Child Fetal Neonatal 2007;92:F366.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.